PG
ABMD

PEAK6 Group’s Abiomed Inc ABMD Stock Holding History

PEAK6 Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$38.9M Buy
95,100
+8,900
+10% +$3.22M 0.17% 96
2018
Q1 		$25.1M Buy
86,200
+36,600
+74% +$9.28M 0.11% 172
2017
Q4 		$9.3M Sell
49,600
-8,900
-15% -$1.66M 0.04% 511
2017
Q3 		$9.86M Buy
58,500
+50,000
+588% +$7.56M 0.05% 423
2017
Q2 		$1.22M Sell
8,500
-48,000
-85% -$6.45M 0.01% 1763
2017
Q1 		$7.07M Sell
56,500
-2,100
-4% -$243K 0.06% 408
2016
Q4 		$6.6M Buy
58,600
+14,200
+32% +$1.65M 0.05% 550
2016
Q3 		$5.71M Buy
44,400
+29,800
+204% +$3.57M 0.04% 617
2016
Q2 		$1.6M Buy
14,600
+6,700
+85% +$667K 0.01% 1421
2016
Q1 		$749K Buy
7,900
+1,900
+32% +$160K 0.01% 1936
2015
Q4 		$542K Sell
6,000
-4,500
-43% -$382K ﹤0.01% 2502
2015
Q3 		$974K Buy
10,500
+7,000
+200% +$617K 0.01% 2218
2015
Q2 		$230K Sell
3,500
-16,500
-83% -$1.1M ﹤0.01% 3576
2015
Q1 		$1.43M Buy
+20,000
New +$1.09M 0.01% 1547

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PEAK6 Group's ABMD Position: Q2 2016 in Review

PEAK6 Group sold out of Abiomed Inc (ABMD) in Q2 2016, closing a stake of 2,907 shares — an estimated $289K sold.

PEAK6 Group first reported a position in ABMD in Q2 2015 and held it in 3 quarters. The position peaked at $370K in Q2 2015. 297 funds tracked by Wall St. Rank hold ABMD as of Q2 2016.

  • PEAK6 Group reported no remaining Abiomed Inc position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 2,907 Abiomed Inc shares in Q2 2016, an estimated $289K.
  • PEAK6 Group first reported a position in Abiomed Inc in Q2 2015 and held it in 3 quarters.
  • PEAK6 Group's Abiomed Inc position peaked at $370K in Q2 2015.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.